Extracorporeal immune modulation in COVID-19 induced immune dysfunction and secondary infections: the role of oXiris® membrane

Minerva Anestesiol. 2021 Mar;87(3):384-385. doi: 10.23736/S0375-9393.20.15124-1. Epub 2020 Dec 17.

Authors

Laura Cascarano¹, Salvatore L Cutuli², Gabriele Pintaudi¹, Eloisa S Tanzarella¹, Simone Carelli¹, Gianmarco Anzellotti¹, Domenico L Grieco¹, Gennaro DE Pascale¹, Massimo Antonelli¹

Affiliations

¹ Unit of Anesthesia, Intensive Care and Clinical Toxicology, Department of Emergency Science, Anesthesiology and Intensive Care, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
² Unit of Anesthesia, Intensive Care and Clinical Toxicology, Department of Emergency Science, Anesthesiology and Intensive Care, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy - sl.cutuli@gmail.com.

PMID: 33331748
DOI: 10.23736/S0375-9393.20.15124-1

No abstract available

Publication types

Case Reports
Letter

MeSH terms

COVID-19 / complications*
COVID-19 / immunology
Humans
Immunomodulation
Male
Membranes, Artificial*
Middle Aged
Renal Replacement Therapy*
Shock, Septic / etiology*
Shock, Septic / immunology
Shock, Septic / therapy*

Substances

Membranes, Artificial